References
Endo F, Kitano A, Uehara I et al (1983) 4-Hydroxyphenylpyruvic acid oxidase deficiency with normal fumaryl-acetoacetase: a new variant form of hereditary hypertyrosinemia.Pediatr Res 17: 92–96.
Endo F, Jatho H, Yamando S et al (1991) A murine model for type III tyrosinemia. Lack of immunologically detectable 4-hydroxyphenylpyruvate dioxygenase enzyme protein in a novel mouse strain with hypertyrosinemia.Am J Hum Genet 48: 704–709.
Giardini O, Catani A, Kennaway NG et al (1983) Chronic tyrosinemia associated with 4-hydroxyphenylpyruvate dioxygenase deficiency with acute intermittent ataxia and without visceral and bone involvement.Pediatr Res 17: 25–29.
Lindstedt S, Holme E, Lock EA et al (1992) Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.Lancet 340: 813–817.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stoppoloni, G., Santinelli, R., Prisco, F. et al. Benign tyrosinaemia: an 18-year follow-up. J Inherit Metab Dis 18, 641–642 (1995). https://doi.org/10.1007/BF02436013
Issue Date:
DOI: https://doi.org/10.1007/BF02436013